0001605514-14-000001.txt : 20140505 0001605514-14-000001.hdr.sgml : 20140505 20140505155119 ACCESSION NUMBER: 0001605514-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140505 DATE AS OF CHANGE: 20140505 EFFECTIVENESS DATE: 20140505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rejuvenan Global Health, Inc. CENTRAL INDEX KEY: 0001605514 IRS NUMBER: 460963250 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-216803 FILM NUMBER: 14813250 BUSINESS ADDRESS: STREET 1: 570 LEXINGTON AVENUE STREET 2: SUITE 1501 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-371-7900 MAIL ADDRESS: STREET 1: 570 LEXINGTON AVENUE STREET 2: SUITE 1501 CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0707 D LIVE 0001605514 Rejuvenan Global Health, Inc. 570 LEXINGTON AVENUE SUITE 1501 NEW YORK NY NEW YORK 10022 212-371-7900 DELAWARE None None Corporation true 2012 Fred F. Nazem 570 Lexington Avenue Suite 1501 New York NY NEW YORK 10022 Executive Officer Founder and Chief Executive Officer Other Health Care Decline to Disclose 06b false 2014-04-18 false true false 0 5275000 3475000 1800000 false 7 0 0 0 false Rejuvenan Global Health, Inc. Fred F. Nazem Fred F. Nazem Founder and Chief Executive Officer 2014-05-02